SCHEMBL23837525

SCHEMBL23837525

C=C(OCOC(=O)c1cccc2c1CBC(NC(=O)CCS(N)(=O)=O)C2)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23837445 0.77 AAK1 (0.31) —
SCHEMBL23837480 0.72 KMT2A (0.34) —
SCHEMBL23837439 0.71 MTNR1A (0.33) —
SCHEMBL23837498 0.71 MTNR1A (0.36) —
SCHEMBL23130304 0.71 MTNR1A (0.34) —
SCHEMBL23130217 0.71 MTNR1A (0.31) —
SCHEMBL23837515 0.71 MTNR1A (0.37) —
SCHEMBL17337149 0.69 PRKCB (0.33) —
SCHEMBL17337150 0.68 PRKCB (0.33) —
SCHEMBL23837590 0.68 ALDH1A1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback